Nicholas Franco
Director/Board Member chez Echo-Sense, Inc.
Provenance du réseau au premier degré de Nicholas Franco
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
31
| Subsidiary | Pharmaceuticals: Major | 31 |
Immune Biosolutions, Inc.
 Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada.
8
| Holding Company | Biotechnology | 8 |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada.
4
| Extinct | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nicholas Franco via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director of Finance/CFO President President | |
| ASCOM HOLDING AG | Telecommunications Equipment | Chairman | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Investor Relations Contact Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO General Counsel Human Resources Officer | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| Actelion Pharmaceuticals UK Ltd. | Director/Board Member Chief Executive Officer Director/Board Member | ||
| University of Montréal | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Carrier Corp.
 Carrier Corp. Industrial MachineryProducer Manufacturing Carrier Corp. manufactures air conditioning, heating, and refrigeration equipment. Its products include residential systems, commercial systems, transport refrigeration, and commercial refrigeration. The company was founded by Willis Haviland Carrier on July 17, 1902 and is headquartered in Jupiter, FL. | Industrial Machinery | Director/Board Member Director/Board Member | |
| University of Bern | College/University | Undergraduate Degree Undergraduate Degree | |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Biotechnology | Director/Board Member Chairman | |
| CARRIER GLOBAL CORPORATION | Industrial Machinery | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin | |
Actelion Pharmaceuticals Korea Ltd.
 Actelion Pharmaceuticals Korea Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Korea Ltd. is a South Korean pharmaceutical company that manufactures pharmaceutical products. The private company is based in Seoul, South Korea. The company was founded in 1983. The CEO is Jenny Jeong. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Max Planck Florida Institute for Neuroscience
 Max Planck Florida Institute for Neuroscience Miscellaneous Commercial ServicesCommercial Services Max Planck Florida Institute for Neuroscience provides research services. It offers its services for neurobiology, brain function, neural circuits, neurological disorders, synaptic networks and bio-imaging. The company was founded in 2008 and is headquartered in Jupiter, FL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CARMAT | Medical Specialties | Chairman Director/Board Member | |
| McGill University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Sherbrooke | College/University | Undergraduate Degree Undergraduate Degree | |
Therillia Development Co., Inc.
 Therillia Development Co., Inc. Pharmaceuticals: MajorHealth Technology Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Founder | |
Tekna Plasma Systems, Inc.
 Tekna Plasma Systems, Inc. Chemicals: SpecialtyProcess Industries Tekna Plasma Systems, Inc. develops, designs and constructs integrated plasma systems. It offers nanoparticle synthesis, coating applications, and powder plasma treatments such as spheroidization and purification for laboratory research and industrial-scale processes. The firm provides spheroidization, nanopowder, deposition and aerospace equipment, nano and spherical powders, powder treatment and logistic options. The company was founded by Maher I. Boulos and Jerzy W. Jurewicz in 1990 and is headquartered in Sherbrooke, Canada. | Chemicals: Specialty | Human Resources Officer | |
| Canada Armed Forces | Sovereign | Chief Tech/Sci/R&D Officer | |
| Canada Foundation For Innovation | Investment Trusts/Mutual Funds | Director/Board Member | |
McGill University Health Center
 McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Hospital/Nursing Management | Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member | |
Gestion Univalor LP
 Gestion Univalor LP Miscellaneous Commercial ServicesCommercial Services Gestion Univalor LP Provides research services. Its services include researcher services, and industry and investors services. The company was founded in 2001 and is headquartered in Montreal, Canada. | Miscellaneous Commercial Services | Chairman | |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Research Council of Canada
 National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Miscellaneous Commercial Services | Director/Board Member | |
Diazon Pharmaceuticals, Inc.
 Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Quebec Blue Cross
 Quebec Blue Cross Multi-Line InsuranceFinance Quebec Blue Cross operates a not-for-profit organization. It offers travel and health insurance products. The company was founded in 1934 and is headquartered in Montreal, Canada. | Multi-Line Insurance | Director/Board Member | |
Léger Robic Richard LLP
 Léger Robic Richard LLP Miscellaneous Commercial ServicesCommercial Services Léger Robic Richard LLP is a private company based in Montréal, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
ExCellThera, Inc.
 ExCellThera, Inc. BiotechnologyHealth Technology ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013. | Biotechnology | Director/Board Member | |
| Nokia GmbH | President |
Statistiques
Internationale
| Canada | 24 |
| Etats-Unis | 9 |
| Suisse | 7 |
| France | 4 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 17 |
| Commercial Services | 13 |
| Consumer Services | 7 |
| Producer Manufacturing | 3 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 204 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 52 |
| Chairman | 44 |
| President | 32 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jean-Pierre Garnier | 28 |
| Mary Ritchie | 26 |
| John Greisch | 25 |
| Louise Proulx | 25 |
| Joseph Scodari | 24 |
| Hendrica Verhagen | 22 |
| David Stout | 19 |
| Robert Cawthorn | 17 |
| Robert Bertolini | 15 |
| Peter Gruss | 15 |
| Otto Schwarz | 13 |
| Simon Buckingham | 13 |
| Michael Jacobi | 12 |
| Marian Borovsky | 11 |
| Isaac Kobrin | 11 |
- Bourse
- Insiders
- Nicholas Franco
- Connexions Sociétés
